Incyte (INCY) Interest Expenses (2010 - 2026)

Incyte (INCY) reported Interest Expenses of $569000.0 for Q1 2026, down 13.79% on a YoY basis from $660000.0 in Q1 2025, and down 2.23% quarter-over-quarter from $582000.0 in Q4 2025.

Incyte (INCY) Interest Expenses (2010 - 2026) Analysis & Trends

Incyte has reported Interest Expenses for 17 years, with the latest figure at $569000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses fell 13.79% year-over-year to $569000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 6.89% YoY), and the FY2025 full-year result was $2.4 million, up 6.49% from the prior year.
  • Interest Expenses for Q1 2026 stood at $569000.0, down from $582000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $804000.0 in Q4 2023, with the low at $419000.0 in Q4 2024.
  • Historically, Interest Expenses has averaged $617294.1 across 5 years, with a median of $641000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Interest Expenses soared 89.42% — and 2024, when it plunged 47.89%.
  • Incyte's Interest Expenses stood at $667000.0 in 2022, then climbed by 20.54% to $804000.0 in 2023, then sank by 47.89% to $419000.0 in 2024, then surged by 38.9% to $582000.0 in 2025, then fell by 2.23% to $569000.0 in 2026.
  • The last three Interest Expenses figures came in at $569000.0 (Q1 2026), $582000.0 (Q4 2025), and $592000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 569,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 569,000.00
Mar 31, 2026 569,000.00
Dec 31, 2025 582,000.00
Dec 31, 2025 582,000.00
Sep 30, 2025 592,000.00
Sep 30, 2025 592,000.00
Jun 30, 2025 594,000.00
Jun 30, 2025 594,000.00
Mar 31, 2025 660,000.00
Mar 31, 2025 660,000.00
Dec 31, 2024 419,000.00
Dec 31, 2024 419,000.00
Sep 30, 2024 774,000.00
Sep 30, 2024 774,000.00
Jun 30, 2024 657,000.00
Jun 30, 2024 657,000.00
Mar 31, 2024 430,000.00
Mar 31, 2024 430,000.00
Dec 31, 2023 804,000.00
Dec 31, 2023 804,000.00